Protagonist Therapeutics (PTGX) Prepaid Assets (2015 - 2026)
Protagonist Therapeutics (PTGX) posted Prepaid Assets of $1.1 million for Q1 2026, up 3.11% sequentially from $1.1 million in Q4 2025, and down 87.39% YoY from $8.7 million in Q1 2025.
Protagonist Therapeutics (PTGX) Prepaid Assets (2015 - 2026) Analysis & Trends
Protagonist Therapeutics has reported Prepaid Assets for 12 years, with the latest figure at $1.1 million in Q1 2026.
- Quarterly Prepaid Assets fell 87.39% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 87.39% YoY) and the FY2025 annual result came in at $1.1 million, down 86.27% from the prior year.
- Prepaid Assets improved to $1.1 million in Q1 2026 per PTGX's latest filing, from $1.1 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $8.7 million in Q2 2025 and troughed at $65000.0 in Q3 2023.
- A 5-year average of $2.6 million and a median of $1.3 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets sank 98.67% in 2023, then surged 10068.42% in 2024.
- Over 5 years, Prepaid Assets stood at $5.7 million in 2022, then slumped by 98.67% to $76000.0 in 2023, then soared by 10068.42% to $7.7 million in 2024, then slumped by 86.27% to $1.1 million in 2025, then gained by 3.11% to $1.1 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $1.1 million, $1.1 million, and $191000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Protagonist Therapeutics | 10.03 Bn | 10.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.79 Mn |
| Mar 31, 2026 | 1.09 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 191,000.00 |
| Jun 30, 2025 | 8.70 Mn |
| Mar 31, 2025 | 8.68 Mn |
| Dec 31, 2024 | 7.73 Mn |
| Sep 30, 2024 | 217,000.00 |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.01 Mn |
| Dec 31, 2023 | 76,000.00 |
| Sep 30, 2023 | 65,000.00 |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 1.49 Mn |
| Dec 31, 2022 | 5.71 Mn |
| Sep 30, 2022 | 436,000.00 |
| Jun 30, 2022 | 1.79 Mn |
| Mar 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | 1.52 Mn |
| Sep 30, 2021 | 8.88 Mn |